Breast cancer is recognized as a highly heterogeneous disease in terms of biological features, prognosis and treatment sensitivity. In the past decades access to anti-HER2 drugs has been driven by the ...
Breast cancer is a major health concern, and its accurate diagnosis and management depend on identifying its histological type and biological subtype. Semaphorin-3A (SEMA3A) is a membrane protein with ...